High‐Resolution PM 2.5 Mortality Projections With Machine Learning Reveal Global Inequities Under Future Climate and Socioeconomic Pathways
GeoHealth · 2026-11 · 10 (11)
DOI: 10.1029/2026gh001829 ↗Abstract
Abstract Fine particulate matter (PM 2.5 ) remains a leading environmental risk to global health, yet projections of future PM 2.5 ‐attributable mortality remain uncertain because of coarse model resolution and difficulty disentangling the effects of emissions, climate change, and land use. Here, we present a high‐resolution assessment of present‐day (2010) and future (2050) PM 2.5 ‐related mortality by integrating Earth system modeling, machine learning, and epidemiological analysis within a factorial forcing framework. We apply an Extreme Gradient Boosting model to bias‐correct and spatially refine Community Earth System Model simulations to 0.1° × 0.1° resolution. Using the Global Exposure Mortality Model, we estimate age‐ and cause‐specific mortality under four Shared Socioeconomic Pathways (SSP1, SSP2, SSP3, SSP5), explicitly isolating the contributions of emissions, climate change, and land use change. We estimate a global PM 2.5 ‐attributable mortality burden of approximately 6.13 (95% uncertainty interval: 5.77–6.48) million deaths in 2010. Future mortality trajectories diverge sharply across SSPs: the sustainable pathway (SSP1) reduces global mortality by approximately 1.1 million deaths by 2050, whereas the regional rivalry pathway (SSP3) increases mortality by approximately 0.5 million deaths. Although emissions remain the dominant driver, climate change consistently offsets parts of health benefits achieved through emission reductions. Mortality impacts are concentrated among older populations (≥60 years) and disproportionately affect low‐ and middle‐income countries. A complementary analysis using SSP‐specific population projections demonstrates that future demographic change can substantially modify the projected mortality burden. Our findings underscore the need for integrated emission mitigation, climate action, and public health adaptation to achieve equitable and sustained reductions in PM 2.5 ‐related mortality.
EUVIMED